LINC01603

Across TCGA pan-cancer cohorts, LINC01603 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC01603 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher LINC01603 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01603 expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCS show a favorable association.

CHOL, HNSC, and DLBC are the cancer types where LINC01603 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	DFS	Tertile	III,IV	0.031	0.505	.003	63	view →
HNSC	OS	Tertile	IV	0.796	0.663	.005	50	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	45	view →
UCS	OS	Tertile	III,IV	0.619	0.351	.018	30	view →
SKCM	OS	Tertile	II,III,IV	0.899	0.671	.007	30	view →
UVM	DFS	Tertile	All	0.248	0.803	<.001	27	view →
OV	DFS	Tertile	IV	0.277	0.636	<.001	26	view →
KIRC	DFS	Quartile	III,IV	0.718	0.522	.003	23	view →
KICH	DFS	Tertile	II,III,IV	0.537	0.945	.031	16	view →
ESCA	OS	Quartile	II,III,IV	0.830	0.592	.021	16	view →
THYM	DFS	Quartile	All	0.716	0.947	.009	15	view →
LUSC	DFS	Quartile	III,IV	0.465	0.704	.017	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC01603–CHOL (DFS)

Open the CHOL breakdown →